Thymosin Alpha-1 (5mg/10mg)

What is Thymosin Alpha-1?

Approved pharmaceutical in 35+ countries. Enhances T-cell maturation, NK cells, and dendritic cells.

Listed vial contents: 5mg / 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.

What mechanisms are being studied?

Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue. It activates toll-like receptors (TLR-2 and TLR-9) on dendritic cells, promoting T-cell maturation, differentiation, and function. It enhances NK cell cytotoxicity, increases MHC class I expression, and bridges innate and adaptive immunity.

What are the research questions?

• Hepatitis B and C: Approved as Zadaxin® in 35+ countries for chronic hepatitis treatment.
• Cancer immunotherapy adjunct: Used alongside chemotherapy and immunotherapy to enhance immune function. Studied in melanoma, hepatocellular carcinoma, and NSCLC.
• Vaccine enhancement: Improves vaccine response in immunocompromised populations (elderly, HIV, transplant recipients).
• COVID-19 and viral infections: Significantly reduced mortality in critically ill COVID-19 patients.
• Immune aging (immunosenescence): Restores declining T-cell function associated with aging.

What does the published work describe?

Garaci E et al. (Int J Immunopharmacol 2000) — Comprehensive review. Approved as Zadaxin® in 35+ countries. COVID-19: Wu M et al. — Significantly reduced mortality in critically ill patients. Maio M et al. — Improved survival in melanoma when combined with dacarbazine + IFN-alpha.

What are the limits of this evidence?

The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.

Study references

1. Garaci E et al. Int J Immunopharmacol 2000

These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.

How should I check lot documentation?

Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. Generated sample reports illustrate the reporting flow and are not evidence of testing, purity or accreditation.